Tuberculous peritonitis developing during chemotherapy for pulmonary and intestinal tuberculosis: A case report

Respirology

Volumn 10, Issue 2, 2005, Pages 257-260

  Kasahara, Kei ^a   Fukuoka, Atsuhiko ^a   Murakawa, Koichi ^b   Okamura, Hideo ^c   Mikasa, Keiichi ^a   Narita, Nobuhiro ^d   Kimura, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Division of Central Clinical Laboratory   (Japan)

^c Nishinara National Hospital   (Japan)

^d Nara Koseikai Hospital   (Japan)

Author keywords

CA125; Paradoxical response; Tuberculous peritonitis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASCITES; CASE REPORT; CHEMOTHERAPY; DRUG SENSITIVITY; EMERGENCY SURGERY; GREATER OMENTUM; HUMAN; INTESTINE PERFORATION; INTESTINE TUBERCULOSIS; LAPAROSCOPY; LUNG TUBERCULOSIS; MALE; PARIETAL OMENTUM; PATHOGENESIS; PERITONEUM ADHESION; PRIORITY JOURNAL; TUBERCULOUS PERITONITIS;

ANTIBIOTICS, ANTITUBERCULAR; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; ISONIAZID; LAPAROSCOPY; MALE; MIDDLE AGED; PERITONITIS, TUBERCULOUS; RIFAMPIN; TIME FACTORS; TUBERCULOSIS, GASTROINTESTINAL; TUBERCULOSIS, PULMONARY;

EID: 18344386432     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00670.x     Document Type: Article

References (12)

1. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am. J. Gastroenterol 1993; 88: 989-99.
2. Paustian FF, Marshall JB. Intestinal tuberculosis. In: Berk JE and Bockus HL (eds). Gastroenterology, 4th edn. WB. Saunders, Philadelphia, 1985; 2018-36.
3. Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N. Engl. J. Med. 1969; 281: 1091-4.
4. Tamura S, Sakamoto Y, Morita M et al. Active intestinal tuberculosis complicated with tuberculous peritonitis. Syokakika 1986; 4: 517-22 (in Japanese).
5. Inoue Y, Kanamori Y, Miura N et al. A case of tuberculous mesenteric lymphadenitis detected by abdominal symptom after 4 months' antituberculous chemotherapy against pulmonary tuberculosis. Kekkaku 1991; 66: 543-51 (in Japanese).
6. Konishi H, Kuwahara O, Miyazaki M, Nishikawa H. A case of tuberculous mesenteric lymphadenitis and peritonitis with symptoms of acute abdomen. Kekkaku 1995; 70: 117-20 (in Japanese).
7. Urakami E. Differentail diagnosis of tuberculosis-(a). A relapse of tuberculosis in the early stage of chemotherapy. Kekkaku 1982; 57: 544-8 (in Japanese).
8. Chambers ST, Hendrickse WA, Record C, Rudge P, Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet 1984; 2: 181-4.
9. Hung SC, Chang SC. New pulmonary lesions during therapy for extrapulmonary tuberculosis. Chest 1999; 116: 1794-7.
10. Cheng VC, Ho PL, Lee RA et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 2002; 21: 803-9.
11. Cheng VC, Yam WC, Woo PC et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur. J. Clin. Microbiol. Infect. Dis. 2003; 22: 597-602.
12. O'Riordan DK, Deery A, Dorman A, Epstein OE. Increased CA125 in a patient with tuberculous peritonitis: case report and review of published works. Gut 1995; 36: 303-5.